Formula Growth LTD Pacira Bio Sciences, Inc. Transaction History

Formula Growth LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$51.24 - $58.89 $187,845 - $215,890	3,666 Added 9.36%	42,832 $2.28 Million
Q1 2022 May 13, 2022	SELL	$60.03 - $76.49 $40,340 - $51,401	-672 Reduced 1.69%	39,166 $2.99 Million
Q4 2021 Feb 14, 2022	SELL	$47.97 - $62.21 $805,896 - $1.05 Million	-16,800 Reduced 29.66%	39,838 $2.4 Million
Q1 2021 May 14, 2021	BUY	$59.31 - $78.82 $3.36 Million - $4.46 Million	56,638 New	56,638 $3.97 Million

263

50.4M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Formula Growth LTD, based on Form 13F filings with the SEC.

Stay updated on Formula Growth LTD with notifications on news.